Benefitfocus, Inc. BNFT shares climbed 50.24% to $34.51. The volume of Benefitfocus shares traded was 3785% higher than normal. Benefitfocus reported a Q4 loss of $0.54 per share on revenue of $40.2 million and received an equity investment from Mercer, a wholly-owned subsidiary of Marsh & McLennan Companies MMC.
Second Sight Medical Products, Inc. EYES shares rose 24.20% to $13.91. The volume of Second Sight Medical Products shares traded was 2594% higher than normal. On Tuesday, Second Sight Medical announced its first commercial implants of the Argus II retinal prosthesis system in France.
Xencor, Inc. XNCR shares moved up 3.72% to $15.05. The volume of Xencor traded was 1376% higher than normal. Xencor priced a public offering of common stock.
The Rubicon Project, Inc. RUBI surged 10.35% to $19.73. The volume of Rubicon Project shares traded 1130% higher than normal. Rubicon Project reported upbeat quarterly results and issued a strong guidance.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in